← Back to Search

Provider Coaching for MAT in Opioid Use Disorder

N/A
Waitlist Available
Led By Faye Taxman, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Site must have the funds to pay for medications for the duration of the study (24 months) from grants, insurance, or private pay
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months, 24 months
Awards & highlights

Study Summary

This trial will explore whether adding coaching and support to providers who offer medication assisted treatment (MAT) to justice-involved populations will help more people access this life-saving care.

Who is the study for?
This trial is for healthcare providers in jail/community settings who are committed to using or increasing the use of medication-assisted treatment (MAT) for individuals with opioid use disorder. Participants must have leadership support, agree to share data, and secure funds to cover medication costs for two years.Check my eligibility
What is being tested?
The study is examining the effectiveness of two evidence-based practices—NIATx Coaching and ECHO—to enhance MAT usage among justice-involved populations. It aims to foster better implementation strategies within participating sites.See study design
What are the potential side effects?
Since this trial focuses on implementation practices rather than direct medical interventions, it does not involve side effects in the traditional sense. However, there may be indirect impacts on patient care that will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My treatment costs are covered for 24 months by insurance, grants, or out-of-pocket.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Number of Prescribers using MOUD
Percent of Eligible Justice Involved Persons initiated and on MOUD
Secondary outcome measures
Percent of sites that continue to use MOUD post intervention
Other outcome measures
NIATx Fidelity

Trial Design

4Treatment groups
Experimental Treatment
Group I: Low-Dose NIATx Coaching & No ECHOExperimental Treatment1 Intervention
Attend an in-person Kick-Off Meeting with Study Team & Coaches One-hour conference call with Executive Sponsor Two-hour NIATx webinar training with Change Leader/Team Three (one-hour) coaching calls at months 4, 8, and 12 with Change Leader/Team
Group II: Low-Dose NIATx Coaching & ECHOExperimental Treatment2 Interventions
Attend an in-person Kick-Off Meeting with Study Team & Coaches One-hour conference call with Executive Sponsor Two-hour NIATx webinar training with Change Leader/Team Three (one-hour) coaching calls at months 4, 8, and 12 with Change Leader/Team Prescribers participate in 12 monthly (one-hour) ECHO video conference calls
Group III: High-Dose NIATx Coaching & No ECHOExperimental Treatment1 Intervention
Attend an in-person Kick-Off Meeting with Study Team & Coaches 4-hour onsite visit 11 monthly (one-hour) NIATx coaching calls
Group IV: High-Dose NIATx Coaching & ECHOExperimental Treatment2 Interventions
Attend an in-person Kick-Off Meeting with Study Team & Coaches 4-hour onsite visit (NIATx Training) 11 monthly (one-hour) NIATx coaching calls Prescribers participate in 12 monthly (one-hour) ECHO video conference calls
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ECHO
2022
N/A
~160

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,123 Total Patients Enrolled
George Mason UniversityOTHER
58 Previous Clinical Trials
48,530 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,329 Total Patients Enrolled

Media Library

ECHO Clinical Trial Eligibility Overview. Trial Name: NCT04363320 — N/A
Opioid Use Disorder Research Study Groups: High-Dose NIATx Coaching & ECHO, Low-Dose NIATx Coaching & No ECHO, High-Dose NIATx Coaching & No ECHO, Low-Dose NIATx Coaching & ECHO
Opioid Use Disorder Clinical Trial 2023: ECHO Highlights & Side Effects. Trial Name: NCT04363320 — N/A
ECHO 2023 Treatment Timeline for Medical Study. Trial Name: NCT04363320 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total participant count in this clinical endeavor?

"Affirmative. Clinicaltrials.gov records reveal that this clinical trial began recruiting on July 30th, 2020 and has since been updated to include 300 subjects from 1 location."

Answered by AI

Is recruitment still underway for this clinical trial?

"Affirmative. The clinicaltrials.gov website indicates that this trial, which commenced on July 30th 2020, is actively searching for participants. 300 individuals need to be recruited from a single location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Fostering MAT Use in Justice Populations
2020. "Fostering MAT Use in Justice Populations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04363320.
~57 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top